patient

Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study

Key Points
In MDS, health-related quality of life (HRQoL) was worse for vulnerable participants and those with worse prognosis.

Lower-risk MDS was associated with better HRQoL, but this relationship was lost among the vulnerable.

What is the IPSS-M for MDS?

In this webinar, Dr. Gail Roboz discusses the Molecular

Addressing Barriers and Challenges to Patient Care - 2023 Omaha Patient and Family Hybrid Conference

The patient panel discusses this essential topic: Barriers and Challenges to accessing care. Learn their techniques for overcoming these barriers in this session from the Patient and Family Conference.

Survivorship: Life after Diagnosis - 2023 Omaha Patient and Family Hybrid Conference

Watch this session to learn techniques for coping after the diagnosis of a

Transplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid Conference

This session explains why and how patients may be offered a transplant to treat MDS, or

Managing PNH and Complications from the Omaha Patient & Family Hybrid Conference 2023

Learn how to manage your PNH, or

PNH Non-Transplant Therapies and Management -2023 Omaha Patient -Family Hybrid Conference

From the 2023 Omaha Patient and Family Hybrid Conference: PNH Non-Transplant Therapies with Dr. Alex Nester. Learn symptom management and options for therapies in this session which includes questions from the audience.